INFLUENCE OF CHRONOTHERAPY WITH DIFFERENT ANTIHYPERTENSIVE DRUGS ON CIRCADIAN BLOOD PRESSURE PATTERN

Aim. To determine the value of different blood pressure (BP) measurement methods for arterial hypertension (HT) chronotherapy efficacy assessment. Material and methods. Two similar open, randomized, cross-over studies (morning vs evening intake) were carried out. Duration of the initial wash-out period was 2 weeks; duration of both treatment courses — 3 weeks; the interval between courses — 1 week. Only patients with stable HT (mean day-time BP>135/85 mm Hg) were included. Ambulatory BP monitoring (ABPM) was carried out prior to treatment and at the end of both treatment courses. The patients performed home BP monitoring (HBPM) throughout the study. Pharmacokinetics of verapamil (n=14, mean daily dose — 240.0±16.3 mg) was studied to assess compliance with verapamil therapy. In ramipril trial (n=30) its mean daily dose was 8.9±0.7 mg. The following main ABPM variables were analyzed: ABPM means and variability, maximal and minimal values, nocturnal BP fall, parameters of Fourier transformation and smoothness index. The morning and evening BP means and morning BP surge (morning – evening BP) were assessed by HBPM. Student’s t-value and Mahalanobis distance were used to evaluate individual value of each variable (“morning” vs “evening” effect). This analysis was first done separately for each trial. After that, combined data were analyzed. Results. Overall antihypertensive effect was more intense with morning ramipril (p<0.05) intake and evening verapamil intake. The t-values ranged 2.2-2.3 for nocturnal BP fall; 2.0-2.1 for night-time BP variability; 3.8-4.3 for morning BP surge. The t-values of office and 24-hour BP were low (0.2-1.7). Conclusion. Morning BP surge based on HBPM is a good instrument for chronotherapy effect assessment. Evening administration of antihypertensive drugs causes nocturnal BP fall shift towards “dipper” status.

1. Smolensky M.H., Hermida R.C., Ayala D.E. et al. Administration time-dependent effect of blood pressure lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit 2010;15:173-180.

2. Hermida R.C., Ayala D.E., Calvo C. et. al. Chronotherapy of hypertension: Administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Advanced Drug Delivery Reviews 2007; 59:923-939.

3. Belolipetskaya V.G., Guranda D.F., Fedorova E.Yu. et al. Chronopharmacology of verapamil in Stage I-II arterial hypertension. Kardiovaskuljarnaja profilaktika i terapija 2009;8:13-19. Russian (Белолипецкая В.Г., Гуранда Д.Ф., Федорова Е.Ю., Горбунов В.М., Белолипецкий Н.А., Жезлова А.В., Исайкина О.Ю., Жабина Е.А., Колтунов И.Е. Хронофармакокинетика верапамила у больных АГ I-II степени. Кардиоваскулярная профилактика и терапия 2009;8:13-19).

4. SAS User`s Guide: Statistics Version 5 Edition. Cary NC: SAS Institute Inc.; 1985.

5. Zuther P., Witte K., Lemmer B. АВРМ-FIT and CV-SORT: an easy-to-use software package for detailed analysis of data from ambulatory blood pressure monitoring. Blood Press Monit 1996;1:347-354.

6. Rizzoni D., Castellano M., Muiesan M.L. et al. Beyond trough:peak ratio: a new index of the smoothness of the antihypertensive effect of a drug. High Blood Press 1997;6:110-115.

7. Rao K.R. Linear Statistical Inference and recommendations for their use. Moscow: Nauka; 1968. Russian (Рао К.Р. Линейные статистические методы и рекомендации по их применению. М.: Наука; 1968).

8. Olbinskaja L.I., Martynov A.I., Hapaev B.A. Blood pressure monitoring in cardiology. M.: Russkij vrach; 1998. Russain (Ольбинская Л.И., Мартынов А.И., Хапаев Б.А. Мониторирование артериального давления в кардиологии. М.: Русский врач; 1998).

9. Gorbunov V.M., Oganov R.G., Deev A.D. Comparative informative value of different ways to analyze the results of ambulatory blood pressure monitoring in evaluating the effectiveness of antihypertensive therapy. Kardiovaskuljarnaja terapija i profilaktika 2003;1:17-25. Russian (Горбунов В.М., Оганов Р.Г., Деев А.Д. Сравнительная информативность различных способов анализа результатов суточного мониторирования артериального давления в оценке эффективности антигипертензивной терапии. Кардиоваскулярная терапия и профилактика 2003;1:17-25).

10. Kitahara Y., Saito F., Akao M. et al. Effect of morning and bedtime dosing of clinidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypernesive patients. J Cardiovasc Pharmacol 2004;43:68-73.

11. Hermida R.C., Ayala D.E., Mojon A., Fernandez J.R. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hyper-tens 2008;21:948-954.

12. White W.B., Anders R.J., Maclntyre J.M., Black H.R., Sica D.A.. Nocturnal dosing of of a novel delivery system of verapamil for systemic hypertension. Verapamil Study Group. Am J Cardiol 1995;76:375-380.

13. White W.B., Mehrotra D.V., Black H.R., Fakouhi T.D. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers) COER-Verapamil Study Group. Am J Cardiol 1997;80:469-474.

14. Dilger K., Eckhardt K., Hofmann U. et al. Chronopharmacology of intravenous and oral modified verapamil. Br J Clin Pharmacol 1999;47:413-419.

15. Hermida R.C., Ayala D.E. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension 2009;54:40-46.

16. Kohno I., Ijiri H., Takusagawa M. et al. Effect of imidapril in dipper and nondipper hypertensive patients: comparison between morning and evening administration. Chronobiol Int 2000;17:209-219.

17. Palatini P., Parati G. Modulation of 24-h blood pressure profiles: a new target for treatment? (Editorial commentaries). J Hypertens 2005; 23 (10):1799-1801.

18. MacMahon S., Peto R., Cutler J. et. Al. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774.

19. Collins R., Peto R., Macmahon S. et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335:827-838.

20. Parati G., Omboni S., Bilo G. Home blood pressure measurements will increasingly replace ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Hypertension 2009;54:181-187.

21. Kario K. Morning surge in blood pressure and cardiovascular risk. Evidence and perspectives. Hypertension 2010;56:765-773.

22. Svensson P., Faire U.,Sleight P., et al. Comparative Effect of Ramipril on Ambulatory and Office Blood Pressure. A HOPE Substudy. Hypertension 2001;38:E28-E32.

23. Staessen J.A., Fagard R., Thijs L. et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-764.